Search

everythinglearnresearchcommunity

for

Search:↓

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

The new assay can track and measure melanosome transfer between skin cells, confirming filopodia's role in this process.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Some chemotherapy can cause permanent hair loss.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Skin problems can be caused or worsened by physical forces and pressure on the skin.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Apoptosis is crucial for healthy skin and treating skin diseases.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Mutations in the PTPRQ gene cause significant balance issues in mice due to hair bundle defects in the inner ear.

Skin cell clumping for hair growth is improved by a protein called fibronectin, which helps cells stick and move better.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.